BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 11, Issue 26
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (4881)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.
Item 
Count 
PDF196
WORD25
HTML2228
Figures (1-4)521
Tables (1-4)458
 Sum=3428
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse254
Download1012
 Sum=1266
Sep 16, 2023 (publication date) through Oct 30, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Sep 16, 2023; 11(26): 6105-6121
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6105
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Immunization approaches against coronavirus disease 2019. COVID: Coronavirus disease 2019.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2  Assignment of the included coronavirus-infected cases at their groups.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3  Frequency of interventions in included patients.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Flow chart of patients in the study. A = casirivimab/imdevimab; B = remdesivir; C = favipiravir.
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345